Northeast Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $267K | Sell |
508
-7
| -1% | -$3.93K | 0.01% | 184 |
|
|
2026
Q1 | $289K | Hold |
515
| – | – | 0.01% | 171 |
|
|
2025
Q4 | $348K | Sell |
515
-4
| -0.8% | -$2.72K | 0.01% | 155 |
|
|
2025
Q3 | $332K | Sell |
519
-14
| -3% | -$8.5K | 0.01% | 148 |
|
|
2025
Q2 | $286K | Hold |
533
| – | – | 0.01% | 162 |
|
|
2025
Q1 | $224K | Hold |
533
| – | – | 0.01% | 173 |
|
|
2024
Q4 | $220K | Sell |
533
-5
| -0.9% | -$2.19K | 0.01% | 172 |
|
|
2024
Q3 | $272K | Hold |
538
| – | – | 0.01% | 164 |
|
|
2024
Q2 | $262K | Sell |
538
-23
| -4% | -$11.5K | 0.01% | 167 |
|
|
2024
Q1 | $303K | Sell |
561
-110
| -16% | -$60.1K | 0.01% | 165 |
|
|
2023
Q4 | $372K | Sell |
671
-33
| -5% | -$15.5K | 0.02% | 146 |
|
|
2023
Q3 | $308K | Hold |
704
| – | – | 0.02% | 156 |
|
|
2023
Q2 | $354K | Sell |
704
-145
| -17% | -$69.5K | 0.02% | 148 |
|
|
2023
Q1 | $425K | Sell |
849
-86
| -9% | -$41.2K | 0.03% | 134 |
|
|
2022
Q4 | $381K | Hold |
935
| – | – | 0.02% | 138 |
|
|
2022
Q3 | $305K | Sell |
935
-35
| -4% | -$12.9K | 0.02% | 143 |
|
|
2022
Q2 | $340K | Hold |
970
| – | – | 0.02% | 143 |
|
|
2022
Q1 | $531K | Sell |
970
-180
| -16% | -$94.7K | 0.03% | 133 |
|
|
2021
Q4 | $757K | Sell |
1,150
-32
| -3% | -$20.1K | 0.04% | 119 |
|
|
2021
Q3 | $735K | Sell |
1,182
-131
| -10% | -$88K | 0.04% | 120 |
|
|
2021
Q2 | $829K | Sell |
1,313
-40
| -3% | -$22.1K | 0.04% | 116 |
|
|
2021
Q1 | $662K | Sell |
1,353
-203
| -13% | -$102K | 0.04% | 124 |
|
|
2020
Q4 | $778K | Sell |
1,556
-155
| -9% | -$69.4K | 0.05% | 112 |
|
|
2020
Q3 | $673K | Sell |
1,711
-127
| -7% | -$47K | 0.04% | 114 |
|
|
2020
Q2 | $607K | Hold |
1,838
| – | – | 0.05% | 109 |
|
|
2020
Q1 | $445K | Sell |
1,838
-15
| -0.8% | -$3.92K | 0.04% | 106 |
|
|
2019
Q4 | $484K | Sell |
1,853
-81
| -4% | -$21.3K | 0.04% | 126 |
|
|
2019
Q3 | $526K | Sell |
1,934
-194
| -9% | -$54K | 0.04% | 119 |
|
|
2019
Q2 | $586K | Sell |
2,128
-83
| -4% | -$20.4K | 0.05% | 117 |
|
|
2019
Q1 | $494K | Sell |
2,211
-537
| -20% | -$111K | 0.04% | 116 |
|
|
2018
Q4 | $511K | Sell |
2,748
-114
| -4% | -$23.4K | 0.05% | 108 |
|
|
2018
Q3 | $715K | Sell |
2,862
-75
| -3% | -$18.2K | 0.06% | 107 |
|
|
2018
Q2 | $640K | Sell |
2,937
-330
| -10% | -$68K | 0.05% | 109 |
|
|
2018
Q1 | $625K | Sell |
3,267
-100
| -3% | -$18.5K | 0.06% | 105 |
|
|
2017
Q4 | $527K | Sell |
3,367
-238
| -7% | -$37.5K | 0.04% | 117 |
|
|
2017
Q3 | $561K | Hold |
3,605
| – | – | 0.05% | 112 |
|
|
2017
Q2 | $582K | Sell |
3,605
-249
| -6% | -$40.4K | 0.05% | 111 |
|
|
2017
Q1 | $596K | Sell |
3,854
-100
| -3% | -$13.8K | 0.06% | 106 |
|
|
2016
Q4 | $464K | Sell |
3,954
-30
| -0.8% | -$3.42K | 0.04% | 118 |
|
|
2016
Q3 | $449K | Sell |
3,984
-10
| -0.3% | -$1.05K | 0.04% | 118 |
|
|
2016
Q2 | $371K | Sell |
3,994
-525
| -12% | -$45.1K | 0.04% | 121 |
|
|
2016
Q1 | $354K | Sell |
4,519
-70
| -2% | -$5.04K | 0.04% | 125 |
|
|
2015
Q4 | $335K | Sell |
4,589
-70
| -2% | -$4.99K | 0.03% | 123 |
|
|
2015
Q3 | $346K | Sell |
4,659
-265
| -5% | -$19K | 0.04% | 122 |
|
|
2015
Q2 | $316K | Sell |
4,924
-656
| -12% | -$45.4K | 0.03% | 128 |
|
|
2015
Q1 | $431K | Sell |
5,580
-386
| -6% | -$30K | 0.04% | 122 |
|
|
2014
Q4 | $442K | Hold |
5,966
| – | – | 0.04% | 128 |
|
|
2014
Q3 | $351K | Sell |
5,966
-260
| -4% | -$16.4K | 0.04% | 140 |
|
|
2014
Q2 | $416K | Sell |
6,226
-546
| -8% | -$34.7K | 0.04% | 138 |
|
|
2014
Q1 | $411K | Hold |
6,772
| – | – | 0.04% | 134 |
|
|
2013
Q4 | $360K | Sell |
6,772
-4
| -0.1% | -$211 | 0.04% | 134 |
|
|
2013
Q3 | $338K | Hold |
6,776
| – | – | 0.04% | 129 |
|
|
2013
Q2 | $304K | Buy |
+6,776
| New | +$296K | 0.04% | 126 |
|
Other funds holding IDXX
MBI
CGI
CAM
RG
SIM
BPCE
MJRIC
RP
Northeast Investment Management's IDXX Position: Q2 2026 in Review
Northeast Investment Management reduced its Idexx Laboratories (IDXX) stake by 1.4% in Q2 2026, selling an estimated $3.93K and leaving 508 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #184.
Northeast Investment Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $829K in Q2 2021. 331 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Northeast Investment Management held 508 shares of Idexx Laboratories worth $267K as of Q2 2026.
- Northeast Investment Management sold 7 Idexx Laboratories shares in Q2 2026, an estimated $3.93K.
- Idexx Laboratories made up 0.01% of Northeast Investment Management's portfolio in Q2 2026, its #184 holding.
- Northeast Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Northeast Investment Management's Idexx Laboratories position peaked at $829K in Q2 2021.
- 331 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.